Insights

Innovative Vaccine Platform Greffex’s proprietary GREVAX Universal Platform enables rapid development and production of vaccines within as little as four weeks, offering a significant advantage in responding to infectious disease outbreaks and pandemic scenarios.

Strategic Industry Collaborations Partnerships such as the recent manufacturing agreement with FUJIFILM Diosynth Biotechnologies highlight opportunities for joint production scaling and distribution channels for vaccine commercialization.

Growth and Market Potential With estimated revenues between 10 and 25 million dollars and a specialized focus on vaccine development for high-impact diseases, Greffex presents opportunities to expand its customer base among biotech and pharmaceutical companies seeking innovative solutions.

Niche Specialization Focusing on infectious diseases like influenza, Ebola, Dengue, and others, Greffex offers targeted vaccine solutions that can appeal to government agencies, international health organizations, and global biotech firms investing in infectious disease control.

Technological Flexibility The flexible, state-of-the-art genetic platform positions Greffex as a technological partner for clients seeking customizable, fast-to-market vaccine development, opening avenues for collaborations across various infectious diseases and emerging pathogens.

Similar companies to Greffex, Inc.

Greffex, Inc. Tech Stack

Greffex, Inc. uses 8 technology products and services including WordPress, oEmbed, jQuery, and more. Explore Greffex, Inc.'s tech stack below.

WordPress
Content Management System
oEmbed
Dev Tools
jQuery
Javascript Libraries
YouTube
Video Players
Google Analytics
Web Analytics
GoDaddy
Web Hosting
Apache
Web Servers
jQuery Waypoints
Web Tools And Plugins

Media & News

Greffex, Inc. partnered with Diosynthbiotechnology on May 8th '20.
Greffex, a leading genetic engineering company announced a key manufacturing agreement with FUJIFILM Diosynth Biotechnologies to produce its vaccine in the United States.
Jun 08, 2020 | finance.yahoo.com

Greffex, Inc.'s Email Address Formats

Greffex, Inc. uses at least 1 format(s):

Greffex, Inc. Email Formats	Example	Percentage
FLast@greffex.com	JDoe@greffex.com	41%
First.Last@greffex.com	John.Doe@greffex.com	9%
FLast@greffex.com	JDoe@greffex.com	41%
First.Last@greffex.com	John.Doe@greffex.com	9%

Frequently Asked Questions

Where is Greffex, Inc.'s headquarters located?

Greffex, Inc.'s main headquarters is located at 12635 East Montview Boulevard Suite 280 Aurora, Colorado 80045 United States. The company has employees across 2 continents, including North AmericaAsia.

What is Greffex, Inc.'s phone number?

You can contact Greffex, Inc.'s main corporate office by phone at

+1-720-859-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Greffex, Inc.'s official website and social media links?

Greffex, Inc.'s official website is greffex.com and has social profiles on LinkedIn.

How much revenue does Greffex, Inc. generate?

As of March 2026, Greffex, Inc.'s annual revenue is estimated to be $950K.

What is Greffex, Inc.'s SIC code NAICS code?

Greffex, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Greffex, Inc. have currently?

As of March 2026, Greffex, Inc. has approximately 13 employees across 2 continents, including North AmericaAsia. Key team members include Chief Scientific Officer, Chairman Of The Board: U. S.President & Chief Executive Officer: J. R. P.President, Greffex Investments: W. C.. Explore Greffex, Inc.'s employee directory with LeadIQ.

What industry does Greffex, Inc. belong to?

Greffex, Inc. operates in the Biotechnology Research industry.

What technology does Greffex, Inc. use?

Greffex, Inc.'s tech stack includes WordPressoEmbedjQueryYouTubeGoogle AnalyticsGoDaddyApachejQuery Waypoints.

What is Greffex, Inc.'s email format?

Greffex, Inc.'s email format typically follows the pattern of FLast@greffex.com. Find more Greffex, Inc. email formats with LeadIQ.

When was Greffex, Inc. founded?

Greffex, Inc. was founded in 1999.

Greffex, Inc.

Q: What is Greffex, Inc.'s official website and social media links?

Greffex, Inc.'s official website is greffex.com. Greffex, Inc. has social profiles on LinkedIn.

Q: How many employees does Greffex, Inc. have currently?

Greffex, Inc. has approximately 13 employees.

Q: What technology does Greffex, Inc. use?

Greffex, Inc.'s tech stack includes Font Awesome, MySQL, Chart.js, Google Maps, WordPress.

Q: What is Greffex, Inc.'s NAICS code?

Greffex, Inc.'s NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Biotechnology ResearchColorado, United States11-50 Employees

Greffex™ is a privately held, multi-national company, headquartered in Aurora, Colorado. Established in 1999, Greffex has developed a novel genetic platform for the development and production of vaccines. Our proprietary GREVAX™ Universal Platform delivers vaccines in a faster, more affordable and more efficient manner. Once a pathogen has been identified, Greffex’s team designs and produces a GREVAX™ vaccine in as little as 4 weeks. The state-of-the-art flexibility of the GREVAX™ Universal Platform makes it the ideal delivery vehicle for vaccines against a wide variety of infectious disease, including but not limited to Pandemic Influenza strains, Anthrax and Dengue Fever, as well as Malaria, Hepatitis C, Respiratory Syncytial Virus (RSV), Ebola, HPV, Plague, Tuberculosis and a host of other vaccine candidates.

Company Overview

Headquarters: 12635 East Montview Boulevard Suite 280 Aurora, Colorado 80045 United States
Phone number: +1-720-859-****
Website: greffex.com
SIC Code: 8733 - Noncommercial Research Organizations
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded: 1999
Employees: 11-50